Latest

neuropharmacology

·June 21, 2024·8 min read

Synthetic Peptide Reverses Alzheimer’s Symptoms

Researchers reversed Alzheimer's symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that PHDP5 can cross the blood-brain barrier and restore memory by improving synaptic function. The treatment could delay cognitive decline if administered early. This breakthrough paves the way for new Alzheimer's therapies focusing on brain structure and function.

Brain Cancer Featured Neurology Neuroscience

·June 17, 2024·5 min read

Cancer Drug May Halt Parkinson’s Spread

Researchers discovered a novel therapeutic target for Parkinson's disease, the Aplp1 protein, which facilitates the spread of harmful alpha-synuclein proteins in the brain. Notably, an FDA-approved cancer drug targeting Lag3, a protein that interacts with Aplp1, has shown promise in blocking this spread in mouse models.

This shows the pill and a model of the intestines.

Featured Neuroscience

·June 14, 2024·4 min read

AI-Powered Pills Track Gut Health in Real Time

Scientists have created an AI-powered system to track ingestible devices that monitor disease markers in the gut. This non-invasive technology could help individuals monitor their GI tract health at home. The system uses a wearable coil and AI to precisely locate the device and measure gas concentrations. Researchers aim to refine the device for future human trials.

Featured Neurology Neuroscience

·June 10, 2024·2 min read

FDA Panel Backs Donanemab: New Hope for Early Alzheimer’s Treatment

Eli Lilly’s Alzheimer’s drug, Donanemab, has been recommended for FDA approval by an independent panel. The drug has shown promise in slowing early-stage Alzheimer’s, despite risks like brain swelling. This recommendation follows a prior FDA rejection due to insufficient data. If approved, Donanemab could revolutionize Alzheimer's treatment, offering new hope for patients and their families.

This shows blue pills in an old man's hand.

Featured Neurology Neuroscience

·June 8, 2024·4 min read

Viagra Shows Promise in Boosting Brain Blood Flow for Dementia Prevention

A new study reveals that sildenafil (Viagra) enhances brain blood flow and improves blood vessel function in patients at risk of vascular dementia. This study marks a significant advancement in addressing this condition. The team found that sildenafil increased blood flow in the brain's small and large vessels, potentially preventing dementia. These findings highlight the drug's promise for larger-scale trials to confirm its effectiveness.

Featured Neuroscience

·June 3, 2024·2 min read

Aspirin Eases Inflammation from Sleep Loss

Low-dose aspirin reduces inflammatory responses caused by sleep restriction. Compared to a placebo, aspirin lowered interleukin-6, COX-1/COX-2 cells, and C-reactive protein levels.

Featured Neuroscience Psychology

·June 3, 2024·3 min read

Ozempic May Reduce Alcohol Abuse Risk

Diabetes drugs Wegovy and Ozempic, containing semaglutide, significantly reduce the incidence and recurrence of alcohol-use disorder (AUD). Analyzing health records, researchers observed a 50% to 56% decrease in AUD among patients treated with semaglutide.

Featured Neuroscience

·May 31, 2024·3 min read

SSRIs Reveal New Potential Beyond Depression Treatment

A new study uncovers a key biological process targeted by SSRIs, suggesting new clinical applications. The study found that SSRIs affect membrane trafficking in cells, which might explain their broader effects. Remarkably, a single dose of fluvoxamine in mice enabled drug delivery across the blood-brain barrier. This discovery could lead to SSRIs aiding in the delivery of drugs for conditions like dementia.

Featured Neuroscience

·May 28, 2024·3 min read

Light-Activated Drug Induces Sleep by Targeting Brain Receptors

Researchers developed a light-sensitive drug that enhances adenosine activity in the brain, inducing sleep in mice without genetic modification. This innovation overcomes the limitations of conventional photosensitive drugs, offering precise control over sleep and motivation via A2A receptors.

Featured Neuroscience

·May 24, 2024·6 min read

Psilocybin Induces Brain Hyperconnectivity, Enhancing Mystical Experiences

Psilocybin, the active compound in magic mushrooms, initiates a pattern of dynamic hyperconnectivity in the brain. This brain state is linked to the ego-modifying effects and feelings of oceanic boundlessness commonly reported during psychedelic experiences.

Featured Neurology Neuroscience

·May 21, 2024·8 min read

Ketamine’s Effect on Brain Activity Revealed

A new computational model reveals how ketamine, a widely used anesthetic and antidepressant, affects brain activity. By simulating the drug's interaction with NMDA receptors, the model explains how ketamine alters neuronal firing patterns, leading to altered states of consciousness and potential therapeutic benefits for depression.

Featured Neuroscience

·May 16, 2024·6 min read

GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise

Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain. This "Trojan Horse" approach allows the drug to specifically target the appetite control center, leading to significant weight loss in mice.

1 … 15 16 17 18 19 … 85

neuropharmacology

Synthetic Peptide Reverses Alzheimer’s Symptoms

Cancer Drug May Halt Parkinson’s Spread

AI-Powered Pills Track Gut Health in Real Time

FDA Panel Backs Donanemab: New Hope for Early Alzheimer’s Treatment

Viagra Shows Promise in Boosting Brain Blood Flow for Dementia Prevention

Aspirin Eases Inflammation from Sleep Loss

Ozempic May Reduce Alcohol Abuse Risk

SSRIs Reveal New Potential Beyond Depression Treatment

Light-Activated Drug Induces Sleep by Targeting Brain Receptors

Psilocybin Induces Brain Hyperconnectivity, Enhancing Mystical Experiences

Ketamine’s Effect on Brain Activity Revealed

GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise

Looksmaxxing Trend Poses Health Risks for Young Men

How “Pink Noise” in Conversation Makes Chats Enjoyable

Can Obesity Drugs Protect the Brain?

SuperAger AI Connectome Predicts Alzheimer’s Years Early

Subscribe